Can genes modify stroke outcome and by what mechanisms?
作者信息
Simon Roger P, Meller Robert, Zhou An, Henshall David
机构信息
The Neuroscience Institute, Morehouse Medical School, 720 Westview Dr, SW, Atlanta, GA, 30310-1495, USA.
出版信息
Stroke. 2012 Jan;43(1):286-91. doi: 10.1161/STROKEAHA.111.622225. Epub 2011 Dec 8.
Abstract
摘要
相似文献
1
Can genes modify stroke outcome and by what mechanisms?
Stroke. 2012 Jan;43(1):286-91. doi: 10.1161/STROKEAHA.111.622225. Epub 2011 Dec 8.
2
Predictive genomics of cardioembolic stroke.
Stroke. 2009 Mar;40(3 Suppl):S67-70. doi: 10.1161/STROKEAHA.108.533273. Epub 2008 Dec 8.
3
Basic concepts and potential applications of genetics and genomics for cardiovascular and stroke clinicians: a scientific statement from the American Heart Association.
Circ Cardiovasc Genet. 2015 Feb;8(1):216-42. doi: 10.1161/HCG.0000000000000020. Epub 2015 Jan 5.
4
Perioperative genomics and neurologic outcome: we can't change who we are.
Can J Anaesth. 2009 Aug;56(8):562-6. doi: 10.1007/s12630-009-9122-x. Epub 2009 May 29.
5
Stroke genomics in people of African ancestry: charting new paths.
Cardiovasc J Afr. 2015 Mar-Apr;26(2 Suppl 1):S39-49. doi: 10.5830/CVJA-2015-039.
6
Stroke Genetics, Genomics, and Precision Medicine.
Stroke. 2024 Aug;55(8):2163-2168. doi: 10.1161/STROKEAHA.123.044212. Epub 2024 Mar 21.
7
Genetics, Genomics, and Precision Medicine.
Stroke. 2021 Oct;52(10):3385-3387. doi: 10.1161/STROKEAHA.121.033966. Epub 2021 Sep 2.
8
Special Issue: "Genomics of Stroke".
Genes (Basel). 2022 Feb 25;13(3):415. doi: 10.3390/genes13030415.
9
Blood genomics in human stroke.
Stroke. 2007 Feb;38(2 Suppl):694-8. doi: 10.1161/01.STR.0000250431.99687.7b.
10
Genetic signatures in the treatment of stroke.
Curr Pharm Des. 2015;21(3):343-54. doi: 10.2174/1381612820666140826113502.
引用本文的文献
1
E3 Ubiquitin Ligase Ring Finger Protein 2 Alleviates Cerebral Ischemia-Reperfusion Injury by Stabilizing Mesencephalic Astrocyte-Derived Neurotrophic Factor Through Monoubiquitination.
CNS Neurosci Ther. 2024 Nov;30(11):e70136. doi: 10.1111/cns.70136.
2
Early Rehabilitation After Stroke: a Narrative Review.
Curr Atheroscler Rep. 2017 Nov 7;19(12):59. doi: 10.1007/s11883-017-0686-6.
3
Correction to: Neuroimmune Response in Ischemic Preconditioning.
Neurotherapeutics. 2018 Apr;15(2):511-524. doi: 10.1007/s13311-017-0580-5.
4
Neuroimmune Response in Ischemic Preconditioning.
Neurotherapeutics. 2016 Oct;13(4):748-761. doi: 10.1007/s13311-016-0465-z.
5
Genetics as a molecular window into recovery, its treatment, and stress responses after stroke.
J Investig Med. 2016 Jun;64(5):983-8. doi: 10.1136/jim-2016-000126. Epub 2016 Apr 4.
6
Plasticity of Sensorimotor Networks: Multiple Overlapping Mechanisms.
Neuroscientist. 2017 Apr;23(2):185-196. doi: 10.1177/1073858416638641. Epub 2016 Jul 8.
7
Cerebral Ischemic Preconditioning: the Road So Far….
Mol Neurobiol. 2016 May;53(4):2579-93. doi: 10.1007/s12035-015-9278-z. Epub 2015 Jun 17.
8
Epigenetics and the environment: in search of the "toleroasome" vital to execution of ischemic preconditioning.
Transl Stroke Res. 2013 Feb;4(1):56-62. doi: 10.1007/s12975-012-0235-0. Epub 2013 Jan 8.
9
Ischemic preconditioning alters the epigenetic profile of the brain from ischemic intolerance to ischemic tolerance.
Neurotherapeutics. 2013 Oct;10(4):789-97. doi: 10.1007/s13311-013-0202-9.
10
Spatial and temporal gene expression differences in core and periinfarct areas in experimental stroke: a microarray analysis.
PLoS One. 2012;7(12):e52121. doi: 10.1371/journal.pone.0052121. Epub 2012 Dec 17.
本文引用的文献
1
Multiple preconditioning paradigms converge on interferon regulatory factor-dependent signaling to promote tolerance to ischemic brain injury.
J Neurosci. 2011 Jun 8;31(23):8456-63. doi: 10.1523/JNEUROSCI.0821-11.2011.
2
Proof of concept: pharmacological preconditioning with a Toll-like receptor agonist protects against cerebrovascular injury in a primate model of stroke.
J Cereb Blood Flow Metab. 2011 May;31(5):1229-42. doi: 10.1038/jcbfm.2011.6. Epub 2011 Feb 2.
3
Throwing the cancer switch: reciprocal roles of polycomb and trithorax proteins.
Nat Rev Cancer. 2010 Oct;10(10):669-82. doi: 10.1038/nrc2931.
4
Retinal proteomic changes under different ischemic conditions - implication of an epigenetic regulatory mechanism.
Int J Physiol Pathophysiol Pharmacol. 2010 Jun 30;2(2):148-160.
5
Bid-mediated mitochondrial damage is a key mechanism in glutamate-induced oxidative stress and AIF-dependent cell death in immortalized HT-22 hippocampal neurons.
Cell Death Differ. 2011 Feb;18(2):282-92. doi: 10.1038/cdd.2010.92. Epub 2010 Aug 6.
6
MicroRNAs as effectors of brain function with roles in ischemia and injury, neuroprotection, and neurodegeneration.
J Cereb Blood Flow Metab. 2010 Sep;30(9):1564-76. doi: 10.1038/jcbfm.2010.101. Epub 2010 Jul 7.
7
Is there a place for cerebral preconditioning in the clinic?
Transl Stroke Res. 2010 Jan 14;1(1):4-18. doi: 10.1007/s12975-009-0007-7.
8
Eradicating the mediators of neuronal death with a fine-tooth comb.
Sci Signal. 2010 Jun 8;3(125):pe20. doi: 10.1126/scisignal.3125pe20.
9
Preconditioning-induced ischemic tolerance: a window into endogenous gearing for cerebroprotection.
Exp Transl Stroke Med. 2010 Jan 21;2(1):2. doi: 10.1186/2040-7378-2-2.
10
Polycomb group proteins as epigenetic mediators of neuroprotection in ischemic tolerance.
Sci Signal. 2010 Mar 2;3(111):ra15. doi: 10.1126/scisignal.2000502.
Zotero 插件